MCAF1 and synergistic activation of the transcription of Epstein-Barr virus lytic genes by Rta and Zta.
Epstein-Barr virus (EBV) expresses two transcription factors, Rta and Zta, during the immediate-early stage of the lytic cycle. The two proteins often collaborate to activate the transcription of EBV lytic genes synergistically. This study demonstrates that Rta and Zta form a complex via an intermediary protein, MCAF1, on Zta response element (ZRE) in vitro. The interaction among these three proteins in P3HR1 cells is also verified via coimmunoprecipitation, CHIP analysis and confocal microscopy. The interaction between Rta and Zta in vitro depends on the region between amino acid 562 and 816 in MCAF1. In addition, overexpressing MCAF1 enhances and introducing MCAF1 siRNA into the cells markedly reduces the level of the synergistic activation in 293T cells. Moreover, the fact that the synergistic activation depends on ZRE but not on Rta response element (RRE) originates from the fact that Rta and Zta are capable of activating the BMRF1 promoter synergistically after an RRE but not ZREs in the promoter are mutated. The binding of Rta-MCAF1-Zta complex to ZRE but not RRE also explains why Rta and Zta do not use RRE to activate transcription synergistically. Importantly, this study elucidates the mechanism underlying synergistic activation, which is important to the lytic development of EBV.
Chang
Li-Kwan
LK
Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Taipei, Taiwan.
Chuang
Jian-Ying
JY
Nakao
Mitsuyoshi
M
Liu
Shih-Tung
ST
D001665:Binding Sites; D002460:Cell Line; D015967:Gene Expression Regulation, Viral; D004854:Herpesvirus 4, Human / Q000235:genetics*; D017874:Immediate-Early Proteins / Q000032:analysis / Q000378:metabolism*; D047468:Immunoprecipitation; D011401:Promoter Regions, Genetic; D054730:Protein Interaction Domains and Motifs; D020218:Response Elements; D015534:Trans-Activators / Q000032:analysis / Q000737:chemistry / Q000378:metabolism*; D015533:Transcriptional Activation; D014764:Viral Proteins / Q000032:analysis / Q000737:chemistry / Q000378:metabolism*
C068382:BRLF1 protein, Human herpesvirus 4; C063676:BZLF1 protein, Herpesvirus 4, Human; D017874:Immediate-Early Proteins; D015534:Trans-Activators; D014764:Viral Proteins
Nucleic Acids Res. 1991 May 25;19(10):2661-7
1645863
Nucleic Acids Res. 2000 Oct 15;28(20):3918-25
11024171
Mol Cell Biol. 2003 Apr;23(8):2834-43
12665582
J Biol Chem. 2004 Sep 10;279(37):38803-12
15229220
J Virol. 2001 Jun;75(11):5240-51
11333906
Virology. 2003 Jun 5;310(2):199-206
12781707
J Virol. 2005 Aug;79(15):9635-50
16014926
J Biol Chem. 2005 Apr 8;280(14):13928-35
15691849
J Virol. 1994 Aug;68(8):5184-93
8035517
J Gen Virol. 2007 Sep;88(Pt 9):2463-2472
17698655
Nucleic Acids Res. 2005 Nov 28;33(20):6528-39
16314315
Virology. 2006 Mar 30;347(1):109-16
16406456
J Virol. 1998 Jun;72(6):5128-36
9573284
EMBO J. 2002 Jun 3;21(11):2715-23
12032084
J Virol. 1998 Oct;72(10):7978-84
9733836
EMBO J. 2000 Jun 15;19(12):3080-9
10856251
Nucleic Acids Res. 1991 Mar 25;19(6):1251-8
1851554
EMBO J. 1986 Dec 1;5(12):3243-9
3028777
Nucleic Acids Res. 1999 Aug 1;27(15):2991-3000
10454592
J Virol. 1990 Jun;64(6):2810-8
2159545
J Virol. 1989 Sep;63(9):3878-83
2548003
Mol Cell. 2003 Aug;12(2):475-87
14536086
J Virol. 2007 Mar;81(5):2459-71
17182691
J Mol Biol. 2008 May 30;379(2):231-42
18455188
J Virol. 1989 Feb;63(2):615-23
2536097
J Virol. 1990 Jan;64(1):313-21
2152819
J Virol. 1999 Jun;73(6):4543-51
10233912
Nucleic Acids Res. 1993 Jul 11;21(14):1999-2007
8393562
Biochem Biophys Res Commun. 2000 Mar 16;269(2):302-8
10708547
J Virol. 1999 Dec;73(12):9858-66
10559298
J Biol Chem. 2009 Feb 20;284(8):5165-74
19106100
J Virol. 1990 Aug;64(8):3753-9
2164595
J Virol. 2004 Jul;78(14):7634-44
15220438